Status: Recruiting
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-BCMA/CD70 CAR-T cells in the treatment of refractory systemic lupus erythematosus.
Participants needed: 18
Trial details
Phase: Phase 1Age: 5+Biological sex: AllType: InterventionalSponsor: The Children's Hospital of Zhejiang University School of MedicineUpdated: Apr 25, 2025Locations: 1
Eligibility criteria
Age:≥5 years old; [+7]
Central nervous system (CNS) disease: CNS neurolupus requires intervention withi... [+10]